Cancer genes hypermethylated in human embryonic stem cells

73Citations
Citations of this article
98Readers
Mendeley users who have this article in their library.

Abstract

Developmental genes are silenced in embryonic stem cells by a bivalent histone-based chromatin mark. It has been proposed that this mark also confers a predisposition to aberrant DNA promoter hypermethylation of tumor suppressor genes (TSGs) in cancer. We report here that silencing of a significant proportion of these TSGs in human embryonic and adult stem cells is associated with promoter DNA hypermethylation. Our results indicate a role for DNA methylation in the control of gene expression in human stem cells and suggest that, for genes repressed by promoter hypermethylation in stem cells in vivo, the aberrant process in cancer could be understood as a defect in establishing an unmethylated promoter during differentiation, rather than as an anomalous process of de novo hypermethylation. © 2008 Calvanese et al.

Cite

CITATION STYLE

APA

Calvanese, V., Horrillo, A., Hmadcha, A., Suarez-Álvarez, B., Fernandez, A. F., Lara, E., … Fraga, M. F. (2008). Cancer genes hypermethylated in human embryonic stem cells. PLoS ONE, 3(9). https://doi.org/10.1371/journal.pone.0003294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free